FMP
Bright Minds Biosciences Inc.
DRUG
NASDAQ
Bright Minds Biosciences Inc., a pre-clinical biosciences company, develops 5-HT (serotonin) medicines to improve the lives of patients with severe and life-altering diseases. Its portfolio of selective 5-HT receptor agonists comprises 5-HT2C, 5-HT2A, and 5-HT2C/A for the treatment of epilepsy, pain, and neuropsychiatry. The company has collaboration with National Institutes of Health for the treatment of epilepsy; University of Texas Medical Branch to treat impulse control disorders, such as binge eating; and Medical College of Wisconsin. The company was incorporated in 2019 and is headquartered in Vancouver, Canada.
1.12 USD
-0.07 (-6.25%)
About
ceo
Mr. Ian McDonald
sector
Healthcare
industry
Biotechnology
website
https://brightmindsbio.com
exchange
NASDAQ
Description
Bright Minds Biosciences Inc., a pre-clinical biosciences company, develops 5-HT (serotonin) medicines to improve the lives of patients with severe and life-altering diseases. Its portfolio of selective 5-HT receptor agonists comprises 5-HT2C, 5-HT2A, and 5-HT2C/A for the treatment of epilepsy, pain, and neuropsychiatry. The company has collaboration with National Institutes of Health for the treatment of epilepsy; University of Texas Medical Branch to treat impulse control disorders, such as binge eating; and Medical College of Wisconsin. The company was incorporated in 2019 and is headquartered in Vancouver, Canada.
CIK
0001827401
ISIN
CA10919W4056
CUSIP
10919W108
Address
1500 – 1055 West Georgia Stree...
Phone
647 407 2515
Country
CA
Employee
N/A
IPO Date
Mar 22, 2021
Summary
CIK
0001827401
Exchange
NASDAQ
Industry
Biotechnology
Sector
Healthcare
CUSIP
10919W108
ISIN
CA10919W4056
Country
CA
Price
1.12
Beta
1.53
Volume Avg.
24.98k
Market Cap
4.84M
Shares
-
52-Week
1.09-6.44
DCF
1.31
ROE
-
ROA
-
Operating Margin
-
Debt/Equity
-
P/E
-0.87
P/B
-
Website
https://brightmindsbio.com
Historical Prices
We are unable to load the chart at this time.
Financial Statement
We are unable to load the chart at this time.
Earnings
We are unable to load the chart at this time.
Upgrades and Downgrades
We are unable to load this data!
People Also Watch
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
Latest DRUG News
It looks like there's no news available.
